26 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
, commitment, restriction or Liability of any kind, which would impair or adversely affect such resources and capabilities.
4.5 Solvency. Purchaser … , and execution of this Agreement have involved substantial investment of management time and have required significant commitment of financial, legal, and other
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
:
(a)Notwithstanding the Specified Defaults, each Lender holding a Tranche B Commitment shall fund its pro rata share of $2,500,000 in principal amount … and restated in its entirety as follows:
“Section 3.04 Commitment Termination. The Tranche A Commitment shall terminate automatically without further action
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
Defined Terms
Accounting Terms and Principles
Interpretation
Division
Section 2. THE COMMITMENT AND THE LOANS
Loans
Borrowing Procedures
Funding …
Interest
Prepayments
Commitment Termination
Exit Fee
Specified Return for Tranche B Term Loans
Section 4. PAYMENTS, ETC.
Payments
Computations
Set-Off
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
3432
1.04 Division 3633
Section 2. THE COMMITMENT AND THE LOANS 3633
2.01 Loans 3633
2.02 Borrowing Procedures 3633
2.03 Funding of Borrowings 3634 … Generally; Application 3734
3.02 Interest 3735
3.03 Prepayments 3835
3.04 Commitment Termination 4037
3.05 Exit Fee 4037
Section 4. PAYMENTS, ETC
10-K/A
EX-3.2
p2p ltvxqdr
31 Mar 23
Annual report (amended)
4:21pm
S-3
zp9zqsbu
16 May 22
Shelf registration
4:49pm
424B4
7mx8 499h
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
kbfgl
25 Aug 21
Draft registration statement
12:00am
10-Q
EX-3.2
jlkwdraw
7 Jun 21
Quarterly report
7:17am
10-Q
wvcdee
7 Jun 21
Quarterly report
7:17am
424B1
4ep4vaw av
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
EX-10.2
qe27ig6q
2 Apr 21
IPO registration
3:04pm